Skip to search formSkip to main contentSkip to account menu

IMREG-1

Known as: IMREG 1 
A low molecular weight fraction of human leukocyte dialysates with potential immunostimulatory activity. IMREG-1 is shown to augment and accelerate… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Lymphokines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
A novel methodology for quantitating the enhancement of cutaneous delayed-type hypersensitivity by IMREG-1: a measure of the immunopotentiation of cell-mediated immunity.
IMREG-1, a low-molecular-weight immunomodulator derived from normal human leukocyte dialysates, has been shown to enhance… 
1991
1991
Clinical benefits and recovery of delayed-type hypersensitivity in patients with AIDS-related complex treated with IMREG-1 or placebo.
1990
1990
Experience with IMREG-1, a Leukocyte Derived Immunomodulator on Candidiasis and Progression of Disease in Patients with AIDS-Related Complex
The immunologic properties of extracts of human buffy coat leukocytes were initially described by Lawrence in the 1950’s… 
1990
1990
Development of immunomodulators for treatment of HIV infection.
Although considerable attention has been devoted to development of antiviral drugs for therapy of HIV infection, relatively… 
1988
1988
Erratum: Immunomodulatory Components Present in IMREG-1, an Experimental Immunosupportive Biologic
Due to a production error, Figure 3 in this research paper by Sudhir K. Sinha et al., (Bio/Technology 6:810–815, July '88) was… 
1988
1988
Clinical and immunological effects of IMREG-1 and IMREG-2, two immunoregulators derived from leukocytes
1986
1986
Endogenous Immunomodulators from Human Leukocytes as Agents for Immunorestoration in Patients with Aids
In previous reports, we have called attention to a group of endogenous immunoamplifiers present in human leukocyte dialysates (1… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)